Pathways Knowlegdes
Necessitatibus eius consequatur ex aliquid fuga eum quidem sint consectetur velit
| Pathway | DOIs | Note |
|---|---|---|
| Defective CYP11B2 causes CMO-1 deficiency Accession ID: Reactome:R-HSA-5579009 |
|
Bureik M, Lisurek M, Bernhardt R. The human steroid hydroxylases CYP1B1 and CYP11B2. Biol Chem. 2002 Oct;383(10):1537–51. doi: 10.1515/bc.2002.174. PMID: 12452430.; Mitsuuchi Y, Kawamoto T, Miyahara K, Ulick S, Morton DH, Naiki Y, Kuribayashi I, Toda K, Hara T, Orii T, Yasuda K, Miura K, Yamamoto Y, Imura H, Shizuta Y. Congenitally Defective Aldosterone Biosynthesis in Humans: Inactivation of the P450C18 Gene (CYP11B2) Due to Nucleotide Deletion in CMO I-Deficient Patients. Biochemical and Biophysical Research Communications. 1993 Feb;190(3):864–9. doi: 10.1006/bbrc.1993.1128. |
| Mineralocorticoid biosynthesis Accession ID: Reactome:R-MMU-193993 |
|
Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 2004 Dec;25(6):947–70. doi: 10.1210/er.2003-0030. PMID: 15583024. |
| Cytochrome P450 - arranged by substrate type Accession ID: Reactome:R-MMU-211897 |
|
Guengerich FP. Cytochrome P450s and other enzymes in drug metabolism and toxicity. The AAPS Journal. 2006 Mar 01;8(1):e101–11. doi: 10.1208/aapsj080112.; Lewis DF. 57 varieties: the human cytochromes P450. Pharmacogenomics. 2004 Apr;5(3):305–18. doi: 10.1517/phgs.5.3.305.29827. PMID: 15102545.; Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics. 2004 Jan;14(1):1–18. doi: 10.1097/00008571-200401000-00001. PMID: 15128046.; Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab. 2002 Dec;3(6):561–97. doi: 10.2174/1389200023337054. PMID: 12369887. |
| Endogenous sterols Accession ID: Reactome:R-RNO-211976 |
|
Pikuleva IA. Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther. 2006 Dec;112(3):761–73. doi: 10.1016/j.pharmthera.2006.05.014. PMID: 16872679.; Guengerich FP. Cytochrome P450s and other enzymes in drug metabolism and toxicity. The AAPS Journal. 2006 Mar 01;8(1):e101–11. doi: 10.1208/aapsj080112.; Lewis DF. 57 varieties: the human cytochromes P450. Pharmacogenomics. 2004 Apr;5(3):305–18. doi: 10.1517/phgs.5.3.305.29827. PMID: 15102545. |
| Endogenous sterols Accession ID: Reactome:R-SSC-211976 |
|
Pikuleva IA. Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther. 2006 Dec;112(3):761–73. doi: 10.1016/j.pharmthera.2006.05.014. PMID: 16872679.; Guengerich FP. Cytochrome P450s and other enzymes in drug metabolism and toxicity. The AAPS Journal. 2006 Mar 01;8(1):e101–11. doi: 10.1208/aapsj080112.; Lewis DF. 57 varieties: the human cytochromes P450. Pharmacogenomics. 2004 Apr;5(3):305–18. doi: 10.1517/phgs.5.3.305.29827. PMID: 15102545. |
| Metabolism of steroid hormones Accession ID: Reactome:R-XTR-196071 |
|
Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 2004 Dec;25(6):947–70. doi: 10.1210/er.2003-0030. PMID: 15583024. |
| Biological oxidations Accession ID: Reactome:R-XTR-211859 |
- | |
| Glucocorticoid & Mineralcorticoid Metabolism Accession ID: WikiPathways:WP495 |
- | |
| Biochemical pathways: part I Accession ID: WikiPathways:WP3604 |
|
Michal G. On representation of metabolic pathways. Biosystems. 1998 Jun;47(1-2):1–7. doi: 10.1016/s0303-2647(98)00019-7. PMID: 9715748. |
| Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism Accession ID: WikiPathways:WP4523 |
|
Pascoe L, Curnow KM, Slutsker L, Rösler A, White PC. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci U S A. 1992 Jun 01;89(11):4996–5000. PMID: 1594605; PMCID: PMC49215. |
| Mineralocorticoid biosynthesis Accession ID: WikiPathways:WP5279 |
|
Schiffer L, Barnard L, Baranowski ES, Gilligan LC, Taylor AE, Arlt W, Shackleton CHL, Storbeck K. Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review. The Journal of Steroid Biochemistry and Molecular Biology. 2019 Nov;194():105439. doi: 10.1016/j.jsbmb.2019.105439. |
| Biosynthesis of aldosterone and cortisol Accession ID: WikiPathways:WP508 |
- | |
| Integrated breast cancer pathway Accession ID: WikiPathways:WP3260 |
|
Ellis D, Sothi TD, Avner ED. Glucocorticoids modulate renal glucocorticoid receptors and Na-K ATPase activity. Kidney Int. 1987 Oct;32(4):464–71. doi: 10.1038/ki.1987.233. PMID: 2828745. |
| Renin-angiotensin-aldosterone system (RAAS) Accession ID: WikiPathways:WP4756 |
|
McDowell SE, Coleman JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006 May 20;332(7551):1177–81. PMID: 16679330; PMCID: PMC1463974. |
| Integrated breast cancer pathway Accession ID: WikiPathways:WP1984 |
|
Muñoz E, Courtois G, Veschambre P, Jalinot P, Israël A. Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3. J Virol. 1994 Dec;68(12):8035–44. doi: 10.1128/jvi.68.12.8035-8044.1994. |
| Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH Accession ID: PathBank:SMP0120690 |
- | |
| 11-beta-Hydroxylase Deficiency (CYP11B1) Accession ID: PathBank:SMP0120858 |
- | |
| Corticosterone Methyl Oxidase I Deficiency (CMO I) Accession ID: PathBank:SMP0120641 |
- | |
| Apparent Mineralocorticoid Excess Syndrome Accession ID: PathBank:SMP0120649 |
- | |
| Aldosterone from Steroidogenesis Accession ID: PathBank:SMP0121126 |
- |